↓ Skip to main content

Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events

Overview of attention for article published in Cochrane database of systematic reviews, March 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 tweeters

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
88 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events
Published in
Cochrane database of systematic reviews, March 2012
DOI 10.1002/14651858.cd007695.pub3
Pubmed ID
Authors

Christopher J Cates, Toby J Lasserson

Abstract

An increase in serious adverse events with both regular formoterol and regular salmeterol in chronic asthma has been demonstrated in previous Cochrane reviews.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 88 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
Colombia 1 1%
Germany 1 1%
Unknown 84 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 16 18%
Researcher 13 15%
Student > Ph. D. Student 11 13%
Student > Bachelor 10 11%
Other 10 11%
Other 15 17%
Unknown 13 15%
Readers by discipline Count As %
Medicine and Dentistry 41 47%
Nursing and Health Professions 10 11%
Social Sciences 5 6%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Psychology 4 5%
Other 6 7%
Unknown 18 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 April 2012.
All research outputs
#7,860,058
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#7,738
of 8,923 outputs
Outputs of similar age
#64,559
of 117,578 outputs
Outputs of similar age from Cochrane database of systematic reviews
#96
of 121 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. This one is in the 23rd percentile – i.e., 23% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 11th percentile – i.e., 11% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 117,578 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 121 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.